TickerFacts.

A business in context

BCAX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-08 · 0001470831-26-000883

  2. 8-K · Current report

    Report date 2026-08-21 · 0001628280-26-058937 · Items 1.01,9.01

  3. 4 · Ownership change

    Report date 2026-08-12 · 0001470831-26-000819

  4. 4 · Ownership change

    Report date 2026-08-10 · 0001470831-26-000814

  5. 4 · Ownership change

    Report date 2026-08-10 · 0001470831-26-000813

  6. 4 · Ownership change

    Report date 2026-08-10 · 0001470831-26-000812

  7. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-055765

  8. 8-K · Current report

    Report date 2026-08-11 · 0001628280-26-055500 · Items 2.02,9.01

  9. 4 · Ownership change

    Report date 2026-07-28 · 0001470831-26-000738

  10. 4 · Ownership change

    Report date 2026-07-28 · 0001470831-26-000737

  11. 8-K · Current report

    Report date 2026-07-23 · 0001628280-26-049937 · Items 5.02,7.01,9.01

  12. 4 · Ownership change

    Report date 2026-07-10 · 0001470831-26-000714

  13. 8-K · Current report

    Report date 2026-06-09 · 0001628280-26-042176 · Items 5.07

  14. 8-K · Current report

    Report date 2026-05-21 · 0001628280-26-037377 · Items 8.01,9.01

  15. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-033429

  16. 8-K · Current report

    Report date 2026-05-11 · 0001628280-26-033135 · Items 2.02,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-04-21 · 0001628280-26-027320

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-022010

  19. 8-K · Current report

    Report date 2026-03-30 · 0001628280-26-021868 · Items 2.02,9.01

  20. 8-K · Current report

    Report date 2026-02-24 · 0001193125-26-076560 · Items 1.01,2.02,9.01

  21. 8-K · Current report

    Report date 2026-02-19 · 0001628280-26-009808 · Items 8.01,9.01

  22. 8-K · Current report

    Report date 2026-01-12 · 0001628280-26-001766 · Items 8.01,9.01

  23. 8-K · Current report

    Report date 2025-12-06 · 0002023658-25-000112 · Items 7.01,8.01,9.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0002023658-25-000109

  25. 8-K · Current report

    Report date 2025-11-10 · 0002023658-25-000107 · Items 2.02,9.01

  26. 10-Q · Quarterly report

    Report date 2025-06-30 · 0002023658-25-000098

  27. 8-K · Current report

    Report date 2025-08-12 · 0002023658-25-000094 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-06-09 · 0002023658-25-000082 · Items 5.07

  29. 8-K · Current report

    Report date 2025-06-02 · 0002023658-25-000063 · Items 1.01,9.01

  30. 10-Q · Quarterly report

    Report date 2025-03-31 · 0002023658-25-000039

  31. 8-K · Current report

    Report date 2025-05-13 · 0002023658-25-000034 · Items 2.02,9.01

  32. DEF 14A · Proxy statement

    Report date 2025-06-09 · 0002023658-25-000027

  33. 10-K · Annual report

    Report date 2024-12-31 · 0002023658-25-000012

  34. 8-K · Current report

    Report date 2025-03-27 · 0002023658-25-000006 · Items 2.02,9.01

  35. 8-K · Current report

    Report date 2025-01-13 · 0001193125-25-005002 · Items 7.01,9.01

  36. 10-Q · Quarterly report

    Report date 2024-09-30 · 0002023658-24-000002

  37. 8-K · Current report

    Report date 2024-11-12 · 0001193125-24-255166 · Items 2.02,7.01,9.01

  38. SC 13G · Ownership disclosure

    0001193125-24-226971

  39. SC 13G · Ownership disclosure

    0001104659-24-103150

  40. SC 13D · Ownership disclosure

    0001104659-24-102048

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 14 transaction rows14SGrant / award: 3 transaction rows3AExercise / conversion: 15 transaction rows15MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

32 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-08
2026-09-10
Cohlhepp Ryan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3442.023.43
2026-09-08
2026-09-10
Cohlhepp Ryan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock14058.022.77
2026-09-08
2026-09-10
Cohlhepp Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock17500.03.79
2026-09-08
2026-09-10
Cohlhepp Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
17500.00.0
2026-08-12
2026-08-14
Larson JenniferA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
285000.00.0
2026-08-10
2026-08-12
Hyep Ivan
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock12500.03.79
2026-08-10
2026-08-12
Hyep Ivan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock12500.027.97
2026-08-10
2026-08-12
Hyep Ivan
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
12500.00.0
2026-08-10
2026-08-12
Mazumdar Claire
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock10000.027.98
2026-08-10
2026-08-12
Mazumdar Claire
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock10000.03.79
2026-08-10
2026-08-12
Mazumdar Claire
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
10000.00.0
2026-08-10
2026-08-12
Cohlhepp Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock18750.03.79
2026-08-10
2026-08-12
Cohlhepp Ryan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock18750.027.98
2026-08-10
2026-08-12
Cohlhepp Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
18750.00.0
2026-07-28
2026-07-29
Bender JeremyA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
38950.00.0
2026-07-28
2026-07-29
Oliger Christy J.A · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
38950.00.0
2026-07-10
2026-07-14
Mazumdar Claire
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock10000.03.79
2026-07-10
2026-07-14
Mazumdar Claire
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock9972.028.42
2026-07-10
2026-07-14
Mazumdar Claire
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock28.029.68
2026-07-10
2026-07-14
Mazumdar Claire
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
10000.00.0
2026-07-09
2026-07-10
Cohlhepp Ryan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock536.029.0
2026-07-08
2026-07-10
Cohlhepp Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock18750.03.79
2026-07-08
2026-07-10
Cohlhepp Ryan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock22833.028.76
2026-07-08
2026-07-10
Cohlhepp Ryan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1075.030.35
2026-07-08
2026-07-10
Cohlhepp Ryan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4306.029.8
2026-07-08
2026-07-10
Cohlhepp Ryan
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
18750.00.0
2026-07-08
2026-07-10
Hyep Ivan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock830.030.31
2026-07-08
2026-07-10
Hyep Ivan
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock12500.03.79
2026-07-08
2026-07-10
Hyep Ivan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock22757.028.6
2026-07-08
2026-07-10
Hyep Ivan
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock4413.029.82
2026-07-08
2026-07-10
Hyep Ivan
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
11592.00.0
2026-07-08
2026-07-10
Hyep Ivan
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
908.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0002023658Bicara Therapeutics Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

    Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

    Explore the CPI history ↗